Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soon Thye Lim

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
Blood|March 12, 2025
Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed/Refractory NK/T-Cell LymphomaSeok Jin Kim, Jing Quan Lim, Sang Eun Yoon, et al.
Haematologica|October 15, 2020
No association between <i>ECSIT</i> germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphomaShin Yeu Ong, Jing Quan Lim, Nicholas Grigoropoulos, et al.
Haematologica|November 4, 2017
Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changesSiok-Bian Ng, Tae-Hoon Chung, Seiichi Kato, et al.
British Journal of Haematology|February 1, 2020
Evaluation of the PIK3 pathway in peripheral T-cell lymphoma and NK/T-cell lymphomaDachuan Huang, Tammy Linlin Song, Maarja-Liisa Nairismägi, et al.
JCO Global Oncology|October 22, 2025
Peripheral T-Cell Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study GroupJason Yongsheng Chan, Ayumi Fujimoto, Esther Wei Yin Chang, et al.
Scientific Reports|October 20, 2019
A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter studyKhee Ming Tan, Burton Chia, Jing Quan Lim, et al.
Leukemia & Lymphoma|July 21, 2023
Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter studyEsther Wei Yin Chang, Valerie Shiwen Yang, Shin Yeu Ong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2021
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)Emmanuel Bachy, Vincent Camus, Catherine Thieblemont, et al.
Leukemia|December 15, 2018
Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphomaRou-Jun Peng, Bo-Wei Han, Qing-Qing Cai, et al.
Cancer Discovery|October 15, 2025
Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell LymphomaCheng Huang, Yan Gao, Jianfeng Chen, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Blood|March 12, 2025
Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed/Refractory NK/T-Cell LymphomaSeok Jin Kim, Jing Quan Lim, Sang Eun Yoon, et al.
Haematologica|October 15, 2020
No association between <i>ECSIT</i> germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphomaShin Yeu Ong, Jing Quan Lim, Nicholas Grigoropoulos, et al.
Haematologica|November 4, 2017
Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changesSiok-Bian Ng, Tae-Hoon Chung, Seiichi Kato, et al.
British Journal of Haematology|February 1, 2020
Evaluation of the PIK3 pathway in peripheral T-cell lymphoma and NK/T-cell lymphomaDachuan Huang, Tammy Linlin Song, Maarja-Liisa Nairismägi, et al.
JCO Global Oncology|October 22, 2025
Peripheral T-Cell Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study GroupJason Yongsheng Chan, Ayumi Fujimoto, Esther Wei Yin Chang, et al.
Scientific Reports|October 20, 2019
A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter studyKhee Ming Tan, Burton Chia, Jing Quan Lim, et al.
Leukemia & Lymphoma|July 21, 2023
Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter studyEsther Wei Yin Chang, Valerie Shiwen Yang, Shin Yeu Ong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2021
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)Emmanuel Bachy, Vincent Camus, Catherine Thieblemont, et al.
Leukemia|December 15, 2018
Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphomaRou-Jun Peng, Bo-Wei Han, Qing-Qing Cai, et al.
Cancer Discovery|October 15, 2025
Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell LymphomaCheng Huang, Yan Gao, Jianfeng Chen, et al.
Pageof 19